Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
15/05/202400:46Alliance NewsAlliance NewsLONDON MARKET EARLY CALL: Stocks called up ahead of US CPI data
15/05/202400:46PR Newswire (US)Liaocheng High-tech Zone: Join Hands with Overseas Investors to Promote Extension and Supplement of High-end Equipment Industry Chain
15/05/202400:45PR Newswire (US)SPay Achieves Milestone - Processes Over N2 Billion in Transactions in Just One Year
15/05/202400:44Alliance NewsAlliance NewsGET READY: Burberry, Compass, Imperial Brands and TP ICAP at 0700 BST
15/05/202400:44Alliance NewsAlliance NewsAlliance News UK - start of day
15/05/202400:34PR Newswire (US)Learning Management System Market size is set to grow by USD 44978.02 mn from 2023-2027, adoption of ngdle in the academic sector to boost the market growth, Technavio
15/05/202400:31PR Newswire (Canada)Astronergy publie ses rapports ESG 2023 et des extraits
15/05/202400:30Business WireMaaT Pharma annonce le succès de son Offre Globale de 19,2 millions d’eurosEU:MAATMaat Pharma SA
15/05/202400:30Business WireIkonisys : Hospitex obtient un brevet international pour le kit de cytoinclusion BLOCKfastEU:ALIKOIkonisys SA
15/05/202400:30GlobeNewswire Inc.BGHL (GBP): NAV(s)EU:BGHSBoussard and Gavaudan Holding
15/05/202400:30Business WireVitura : Activité du 1er trimestre 2024NYSE:VTRVentas Inc
15/05/202400:30Business WireVitura: Activity at end-March 2024NYSE:VTRVentas Inc
15/05/202400:30GlobeNewswire Inc.BGHL (EUR): NAV(s)LSE:BGHLBoussard & Gavaudan Holding Limited
15/05/202400:30Business WireMaaT Pharma announces the successful completion of its Global Offering of 19.2 Million EurosEU:MAATMaat Pharma SA
15/05/202400:30Business WireIkonisys: Hospitex to Obtain International Patent for the BLOCKfast Cyto-Inclusion KitEU:ALIKOIkonisys SA
15/05/202400:30PR Newswire (Canada)SEG Solar and Grand Batang City Sign Land Utilization Agreement for Southeast Asia's Largest PV Industrial Park
15/05/202400:22PR Newswire (US)Forum on Disaster Prevention and Mitigation from Grassroots Level Held in Qingdao, Shandong Province
15/05/202400:20Business WireAllianz Increases Operating Profit by 6.8% to 4.0 Billion Euros
15/05/202400:18NEWSBTCXRP Price Faces Uphill Battle: Struggles to Initiate Fresh UpsideCOIN:ETHUSDEthereum
15/05/202400:14CointelegraphMore than one million new tokens have been launched since AprilCOIN:SOLUSDSolana
15/05/202400:11GlobeNewswire Inc.Andes, HiRain, and HPMicro Join Hands to Build RISC-V AUTOSAR Software Ecosystem
15/05/202400:09PR Newswire (US)Beijing China-Germany Forum for Industrial Cooperation and Development--China-Germany (China-Europe) Hidden Champions Forum 2024 Opened
15/05/202400:02GlobeNewswire Inc.Avance Gas Holding Ltd: Key information relating to return of capital and dividend for the first quarter 2024TG:A07Avance Gas Holding Ltd
15/05/202400:01GlobeNewswire Inc.Avance Gas Holding Ltd: First Quarter 2024 Earnings ReleaseTG:A07Avance Gas Holding Ltd
15/05/202400:00Business WireBenevolentAI Announces Further Success With AstraZeneca Collaboration as Novel Heart Failure Target Selected
15/05/202400:00GlobeNewswire Inc.Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025TG:PHGNPharming Group NV
15/05/202400:00GlobeNewswire Inc.Vivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024TG:05YVivoryon Therapeut
15/05/202400:00GlobeNewswire Inc.LEXIBOOK : T4 23-24 FISCAL EN BAISSE DE 14.7% A 6.4M€ VS 7.5M€ SUR T4 22-23. CA ANNUEL EN HAUSSE DE 14.4% A 58.5M€ VS 51.2M€ GRACE A LA CROISSANCE EN FRANCE ET A L’INTERNATIONAL. PREMIERS INVESTISSEMENTS SIGNIFICATIFS EN PUBLICITE AUX USA.EU:ALLEXLexibook Linguistic Electronic System SA
15/05/202400:00Business WireShin-Etsu Chemical to Build a New Plant for Silicone Products in Zhejiang Province, China
15/05/202400:00Business WireInnate Pharma Highlights Abstracts Selected for EHA 2024 CongressNASDAQ:IPHAInnate Pharma SA